IVI and Senegal

Member State Relations

On October 30, 1996, the Permanent Representative of Senegal to the United Nations, H.E. Ibra Deguène Ka, signed the IVI Establishment Agreement.

Ongoing Collaboration

Institut Pasteur de Dakar (IPD) Collaboration

In 2023, IVI and Institut Pasteur de Dakar (IPD) signed a Memorandum of Understanding to partner across three areas: 1) to establish IPD as a regional Center of Training Excellence for Biomanufacturing to equip talented young people, particularly young women, with specialized skills in vaccine research, manufacturing, production, and distribution;  2) to support manufacturing and technology transfer of existing vaccine technologies relevant to Africa to increase vaccine manufacturing on the continent; and 3) to conduct end-to-end vaccine development including lab-to-lab vaccine and process development, and to strengthen Good Clinical Practice and regulatory pathways. 

With IPD’s expansion into new capabilities supported by global funders, IVI’s training sessions aim to provide essential, practical knowledge designed to strengthen capacity in all aspects of biomanufacturing. Capacity-building is a core area of strategic interest outlined by the MOU, with training sessions on-site at IPD beginning directly following the signing ceremony. These sessions will pay particular attention to technology transfer and project management.

Previous Collaboration

Hepatitis E (HEV) Surveillance

In late 2020, IVI received a $500,000 grant from the Bill and Melinda Gates Foundation to conduct seroepidemiology of HEV in Africa. In 2021, IVI formed a consortium with the Institute Pasteur in Dakar, Senegal, the University of Ibadan in Ibadan, Nigeria, and the Institute Nationale de Recherche Biomédicale, in Kinshasa, Democratic Republic of the Congo (DRC). The consortium screened approximately 18,000 blood samples from 19 countries to determine the prevalence of HEV across different demographics, groups, and regions in Africa.